Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-71.71	11.17	39.49
Graham Fair Price	41.43	0.91	0.64
PEG	-61.92	0.01	-0.04
Price/Book	-27.88	0.13	0.17
Price/Cash Flow	-63.98	0.26	0.71
Prices/Earnings	-63.94	1.45	4.03
Price/Sales	-63.94	0.11	0.31
Price/FCF	-63.98	0.26	0.71
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.09	0.09
Operating Margin	0.00	0.03	0.03
ROA	100.00	0.01	< 0.005
ROE	0.01	0.02	100.00
ROIC	< 0.005	0.02	145.98
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.39	-0.28	-39.82
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.35	1.00	-25.92
EPS QOQ	1.06	1.01	-5.31
FCF QOQ	10.02	1.00	-90.00
Revenue QOQ	-0.77	1.00	29.95
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	39.89	19.95	-50.00
Days Sales Outstanding (DSO)	13.27	6.63	-50.00
Inventory Turnover	2.26	4.51	100.00
Debt/Capitalization	0.48	0.36	-25.29
Quick Ratio	1.31	1.35	3.20
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	1.30	1.30	< 0.005
Cash	0.16	0.17	5.38
Capex	< 0.005	< 0.005	< 0.005
Free Cash Flow	0.32	0.64	100.22
Revenue	0.73	1.46	100.01
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	3.35	3.35	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	32.35	8.65	-73.25
Naive Interpretation	Member

06 - Financial Health · Bad

Rating